Recombinant Yeast for Enhanced Xylose Fermentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Native Saccharomyces cerevisiae strains struggle to efficiently ferment xylose from lignocellulosic biomass due to inhibitory compounds and lack of native xylose catabolism enzymes, limiting biofuel production from renewable plant feedstocks.
Innovation Solution
Genetically engineered Saccharomyces cerevisiae strains with reduced Isu1, Hog1, Gre3, Ira1, and Ira2 polypeptides, along with introduced xylose metabolism enzymes, enhance aerobic and anaerobic xylose fermentation capabilities, allowing for improved biofuel production from xylose-containing feedstocks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If native Saccharomyces cerevisiae is used for xylose fermentation, then the fermentation process is simple, but the xylose fermentation rate is low and ethanol production is limited
Solution Approach 1:
The patent applies parameter changes by modifying multiple genetic parameters simultaneously - deleting negative regulatory genes (ISU1, HOG1, GRE3, IRA2, IRA1) and introducing xylose metabolism genes (XYL1, XYL2, XYL3). This multi-parameter genetic modification transforms the yeast's metabolic capabilities to achieve high-rate xylose fermentation and ethanol production from lignocellulosic biomass.
2Productivity
If genetically engineered yeast strains are used to enhance xylose fermentation, then ethanol production increases, but sensitivity to inhibitory compounds from pretreatment becomes a challenge
Solution Approach 1:
The patent converts the harmful effect of inhibitory compounds into a beneficial selection pressure. The genetic modifications (deletions of ISU1, HOG1, GRE3, IRA2, IRA1) that enhance xylose fermentation also confer increased tolerance to pretreatment inhibitors. The strain's improved metabolic efficiency in utilizing xylose allows it to outcompete inhibitor effects and thrive in pretreated hydrolysate conditions, transforming the challenge of inhibitor sensitivity into an advantage for consolidated bioprocessing.
3Productivity
If multiple gene deletions are performed to reduce polypeptide amounts, then xylose fermentation capability improves, but the genetic modification process becomes more complex
Solution Approach 1:
The patent merges multiple genetic modification objectives into a unified strain construction approach. By combining deletions of five negative regulatory genes (ISU1, HOG1, GRE3, IRA2, IRA1) with the introduction of xylose metabolism genes, the patent creates a consolidated genetically modified strain that simultaneously achieves enhanced xylose uptake, improved fermentation rate, and increased inhibitor tolerance. This merging of multiple genetic interventions into a single integrated strain reduces the overall process complexity compared to sequential separate modifications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered yeast strains exhibit increased xylose fermentation rates and ethanol production, overcoming the limitations of native strains by reducing inhibitory compound sensitivity and enhancing metabolic pathways, thus improving biofuel yield from lignocellulosic biomass.
Implementation Method 1
The engineered yeast strains exhibit increased xylose fermentation rates and ethanol production
Data Source
AI summary
The present invention relates to the production of biofuels and chemical feedstocks. The present invention provides recombinant yeast having enhanced xylose fermentation capabilities. Methods of using such recombinant yeast for improved biofuel and chemical feedstock production are also provided.